Skip to content

Clinical trials

Completed Ovarian Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Completed Country / region: Australia Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20043
20053
20064
20072
20084
20095
20103
20135
20142
20152
20163
20175
20185
20194
20203
20211
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
AbbVie3
Amgen3
Gynecologic Oncology Group3
Queensland Centre for Gynaecological Cancer3
AbbVie (prior sponsor, Abbott)2
Arcus Biosciences, Inc.2
Children's Oncology Group2
Hoffmann-La Roche2
MEI Pharma, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms62
Fallopian Tube Neoplasms20
Carcinoma, Ovarian Epithelial13
Neoplasms11
Carcinoma, Non-Small-Cell Lung10
Breast Neoplasms8
Triple Negative Breast Neoplasms8
Colorectal Neoplasms7
Peritoneal Neoplasms7
Stomach Neoplasms7

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.